CIDRZ Awarded Stop TB Partnership TB REACH Grant


The implementation science project, Achieving TB Control in Zambia through Scale-up of Innovative Diagnostic Tools and Proven Active TB Case-Finding Interventions, will conduct systematic health facility and community-based case-finding interventions complemented by highly-sensitive screening and diagnostic tools to initiate a sustained increase in TB case detection in high-burden settings. The project will be implemented in collaboration with the Zambian Ministry of Health and the National Tuberculosis Programme.

Zambia is among the thirty highest TB burden countries globally but has low TB case detection of 58%. Promising diagnostic tools such as Xpert MTB/Rif have shown a limited impact on TB treatment outcomes when placed in health facilities because health system and patient-level barriers to accessing screening services are not addressed. To reach the desired TB detection and treatment impact, placement of highly-sensitive tools must be accompanied with interventions that allow maximal patient access to screening, diagnostic, and treatment services closer to home. This project will target ‘high-risk for TB’ Lusaka peri-urban dwellers in George compound through community awareness raising activities in combination with community and facility-level active TB case-finding and proven screening procedures.

The project is expected to:

  • increase community awareness resulting in increased demand for TB screening
  • increase knowledge about TB/HIV among healthcare workers
  • increase TB screening in all health facility departments with use of exit screening and cough monitors
  • reduce time to TB diagnosis
  • strengthen contact tracing through use of a combination of screening algorithms to ensure that only high-risk patients get a definitive TB diagnostic test. Use of highly sensitive screening and diagnostic tools at the community level will allow maximal access to TB diagnosis.

The Achieving TB Control in Zambia through Scale-Up of Innovative Diagnostic Tools and Proven Active TB Case-Finding Interventions project is supported by the Stop TB Partnership’s TB REACH initiative and is funded by the Government of Canada and the Bill & Melinda Gates Foundation. The Principal Investigator is Dr Monde Muyoyeta MBChB, PhD, Director of CIDRZ TB Programmes.

CIDRZ 2017-18 HealthCorps Fellows

2017 – 2018 CIDRZ HealthCorps Fellows

Belinda Chihota, MSc-Control of Infectious Diseases (London School of Hygiene & Tropical Medicine, UK)

Belinda is from Zimbabwe and has worked with Doctors of the World U.K., the Medical Research Council Uganda Virus Research Institute, and the Zimbabwean Biomedical Research and Training Institute. She will be attached to the International Epidemiological Databases to Evaluate AIDS (IeDEA) study group working on HIV/Hepatitis B co-infection research.

Dr Neha Buddhdev, MD, MSc-Immunology and Global Health (University of Ireland)

Neha is from Kenya and has worked at the U.S. Army Medical Research Directorate-Kenya studying Flavivirus epidemiology. She will be attached to the CIDRZ Enteric Disease and Vaccines Research group and will contribute to our epidemiological studies assessing the burden of enteric pathogens in Lusaka to assist in the design of future vaccines and therapeutics clinical trials.

Marrit Habets, MSc-Microbiology/Immunology (University of Groningen, Netherlands)

Marrit is from the Netherlands and has conducted post-doctoral research on the immune recognition and clearance of Streptococcus pneumonia at the Radboud University Medical Center in Nijmegen (the Netherlands). In addition, she has worked as a laboratory consultant at the Makerere University-Walter Reed Project in Kampala (Uganda) and at the University of the West Indies in Kingston (Jamaica). She will be attached to the CIDRZ Laboratory.

Michelle Eglovitch, MPH-Maternal and Child Health (Boston University, USA)

Michelle is from the USA and has worked as a Research Assistant for the Pregnancy Health Interview Study at Boston University School of Public Health, and as a Program Analyst for Women’s and Infant Health at the Association of Maternal and Child Health Programs. She will be attached to the PMTCT Programme.

Jill Kadota, MPH-Epidemiology and Biostatistics (University of California, Berkeley USA)

Jill is from the USA and has performed data analysis for a randomized trial amongst people living with HIV in Shinyanga, Tanzania. She will be attached to the Analysis Unit.

University of Alabama at Birmingham Sparkman Center for Global Health  – supported CIDRZ HealthCorps Fellows 

Mbaita Shawa, MPH – Global Health (Simon Fraser University, Canada)

Mbaita is from Zambia and has previously worked at the Zambia Center for Applied Health Research and Development (ZCAHRD) on an Early Childhood Development project. She will be attached to our Qualitative Research team.

Dr Chileshe Mabula, MBChB (University of Zambia)

Chileshe is from Zambia and also holds a BA in Human Development from the University of California, San Diego. She has implemented a successful intervention for adolescents living with HIV in Eastern Province, Zambia, and has worked as a Medical Officer in Chipata where she developed a keen interest in improving patient engagement and access to care.  She will be attached to the Clinical Trials Team.

Learn more about our partner The UAB Sparkman Center for Global Health here

CIDRZ is also a host site for Global HealthCorps Fellows

Belia L. Ng’andwe, BA-Development Studies (University of Zambia)

Belia is from Zambia and has worked as Assistant Program Coordinator for Restless Development Zambia responsible for managing/ mentoring interns and volunteer peer educators who implemented project activities on the ground. Belia was behind Restless Development’s ‘Girls Like Us’ project focusing on reducing girls’ vulnerability and sexual reproductive health risks by empowering them with skills to contribute to household income. She will be attached to the Paediatric HIV Department.

Meave Otieno, MSc – Public Health Microbiology (George Washington University Milken Institute of Public Health, USA)

Meave is from Kenya and the USA.  She was a Peace Corps volunteer working as a Health Extension Agent in Togo; has done a practicum with the Elizabeth Glaser Pediatric AIDS Foundation working on research study protocol development; and assisted with data management in a palliative care study of people living with HIV/AIDS while a research trainee at the Children’s National Medical Center. She will be attached to the CIDRZ TB Department.

Fogarty International Center and Office of AIDS Research, NIH Global Health Equity Scholars Consortium, Yale University Research Fellow

Shilpa Iyer, MSc (Pune University, India), PhD (University of Pennsylvania, USA)

Dr Shilpa has conducted post-doctoral research at the prestigious Dr Beatrice Hahn Research Laboratory at the University of Pennsylvania. While at CIDRZ she will conduct an acute HIV-1 infection point-of-care testing study. She will be supervised by Professor Dr Sten Vermund, Dean of the Yale University School of Public Health and Dr Izukanji Sikazwe.